VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares dropped 20% during trading on Friday . The stock traded as low as C$0.12 and last traded at C$0.12. Approximately 1,285,730 shares were traded during mid-day trading, an increase of 384% from the average daily volume of 265,597 shares. The stock had previously closed at C$0.15.
VentriPoint Diagnostics Stock Down 23.3 %
The firm has a market capitalization of C$18.65 million, a price-to-earnings ratio of -3.55 and a beta of 0.39. The company has a current ratio of 0.28, a quick ratio of 6.67 and a debt-to-equity ratio of -58.56. The firm has a fifty day moving average price of C$0.10 and a 200 day moving average price of C$0.13.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
See Also
- Five stocks we like better than VentriPoint Diagnostics
- What is an Earnings Surprise?
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
